Rationale and Design of the Double-Blind, Randomized, Placebo-Controlled Multicenter Trial on Efficacy of Early Initiation of Eplerenone Treatment in Patients with Acute Heart Failure (EARLIER)-Reference-Cited by-同舟云学术

Rationale and Design of the Double-Blind, Randomized, Placebo-Controlled Multicenter Trial on Efficacy of Early Initiation of Eplerenone Treatment in Patients with Acute Heart Failure (EARLIER)

Published:2015-01-08 Issue:2 Volume:29 Page:179-185
ISSN:0920-3206
Container-title:Cardiovascular Drugs and Therapy
language:en
Short-container-title:Cardiovasc Drugs Ther

Author:

Asakura Masanori, ,Yamamoto Haruko,Asai Kuniya,Hanatani Akihisa,Hirata Ken-ichi,Hirayakma Atsushi,Kimura Kazuo,Kobayashi Youichi,Momomura Shin-ichi,Nakagawa Yoshihisa,Nishi Yutaro,Saito Yoshihiko,Satoh Yasuhiro,Yamada Takahisa,Yamashina Akira,Yasuda Satoshi,Yoshikawa Tsutomu,Kada Akiko,Uesaka Hiroyuki,Kitakaze Masafumi

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10557-014-6565-2.pdf

Reference25 articles.

1. Chang PP, Chambless LE, Shahar E, et al. Incidence and survival of hospitalized acute decompensated heart failure in four US communities (from the atherosclerosis risk in communities study). Am J Cardiol. 2014;113:504–10.

2. Guidelines for treatment of acute heart failure (JCS 2011). Cir J: Off J Jpn Circ Soc. 2013;77:2157–201.

3. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European society of cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012;14:803–69.

4. Mentz RJ, Bakris GL, Waeber B, et al. The past, present and future of renin-angiotensin aldosterone system inhibition. Int J Cardiol. 2013;167:1677–87.

5. O’Connor CM, Fiuzat M, Swedberg K, et al. Influence of global region on outcomes in heart failure beta-blocker trials. J Am Coll Cardiol. 2011;58:915–22.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse events associated with early initiation of Eplerenone in patients hospitalized for acute heart failure;International Journal of Cardiology;2024-11

2. Effect of eplerenone on clinical stability of Japanese patients with acute heart failure;International Journal of Cardiology;2023-03

3. Efficacy and Safety of Early Initiation of Eplerenone Treatment in Patients with Acute Heart Failure (EARLIER trial): a multicentre, randomized, double-blind, placebo-controlled trial;European Heart Journal - Cardiovascular Pharmacotherapy;2020-11-11

4. Reappraisal on pharmacological and mechanical treatments of heart failure;Cardiovascular Diabetology;2020-05-06

5. Short-term and long-term prognosis in patients with Q-myocardial infarction complicated by acute heart failure with hyperglycemia;Zaporozhye Medical Journal;2019-10-01